From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

MI MAY BE LESS SEVERE IN ASPIRIN USERS.

Several studies show that aspirin helps prevent cardiovascular events, particularly in patients with known coronary artery disease, but whether aspirin alters the severity or presentation of these events is unclear. This large multicenter observational study looked at how myocardial infarctions differ between aspirin users and nonusers. Of 2114 patients with documented MI, 332 (16 percent) had been taking aspirin. These patients more commonly had previous infarction, stroke, or angina than the aspirin nonusers, and were less likely than the nonusers to receive thrombolytic therapy for the current infarction. About 65 percent of aspirin users had current non-Q-wave infarctions, as compared with 49 percent of nonusers, and 30 percent of users' infarctions were small, versus 22 percent of nonusers' infarctions. Aspirin use was independently associated with a greater likelihood of non-Q-wave and small infarctions after adjustment for multiple factors, including previous coronary disease, use of other medications before the MI, and use of thrombolytic therapy. Comment: Although this population-based study was not a randomized trial, it hints at yet another benefit of aspirin -- a shift in the pattern of myocardial infarction to one of less severe damage.

— CD Mulrow

Published in Journal Watch General Medicine July 21, 1995

Citation(s):

Col NF et al. Does aspirin consumption affect the presentation or severity of acute myocardial infarction?. Arch Intern Med 1995 Jul 10 155 1386-1389.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1995. Massachusetts Medical Society. All rights reserved.